Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$4.68 - $9.26 $68,103 - $134,751
-14,552 Reduced 38.42%
23,320 $116,000
Q2 2023

Aug 08, 2023

SELL
$8.5 - $10.38 $10,803 - $13,192
-1,271 Reduced 3.25%
37,872 $345,000
Q1 2023

May 08, 2023

BUY
$7.53 - $10.95 $8,034 - $11,683
1,067 Added 2.8%
39,143 $369,000
Q4 2022

Feb 06, 2023

SELL
$9.44 - $13.09 $21,929 - $30,408
-2,323 Reduced 5.75%
38,076 $380,000
Q3 2022

Nov 14, 2022

SELL
$8.14 - $12.25 $4,257 - $6,406
-523 Reduced 1.28%
40,399 $482,000
Q2 2022

Aug 05, 2022

BUY
$6.99 - $10.0 $5,130 - $7,340
734 Added 1.83%
40,922 $335,000
Q1 2022

May 10, 2022

BUY
$7.26 - $10.7 $58,602 - $86,370
8,072 Added 25.13%
40,188 $319,000
Q4 2021

Feb 07, 2022

BUY
$8.8 - $16.0 $57,024 - $103,680
6,480 Added 25.28%
32,116 $301,000
Q3 2021

Nov 10, 2021

SELL
$15.23 - $21.72 $11,742 - $16,746
-771 Reduced 2.92%
25,636 $405,000
Q2 2021

Aug 04, 2021

BUY
$17.8 - $23.5 $20,256 - $26,743
1,138 Added 4.5%
26,407 $571,000
Q1 2021

May 10, 2021

SELL
$17.18 - $22.6 $85,865 - $112,954
-4,998 Reduced 16.51%
25,269 $512,000
Q4 2020

Feb 08, 2021

SELL
$11.5 - $17.96 $85,951 - $134,233
-7,474 Reduced 19.8%
30,267 $542,000
Q3 2020

Nov 12, 2020

SELL
$10.62 - $13.12 $33,612 - $41,524
-3,165 Reduced 7.74%
37,741 $439,000
Q2 2020

Aug 11, 2020

BUY
$7.35 - $10.81 $70,633 - $103,884
9,610 Added 30.71%
40,906 $378,000
Q1 2020

May 08, 2020

BUY
$8.38 - $17.34 $32,665 - $67,591
3,898 Added 14.23%
31,296 $325,000
Q4 2019

Feb 11, 2020

BUY
$11.18 - $18.6 $12,465 - $20,739
1,115 Added 4.24%
27,398 $490,000
Q3 2019

Nov 12, 2019

SELL
$12.09 - $20.46 $5,730 - $9,698
-474 Reduced 1.77%
26,283 $328,000
Q2 2019

Jul 31, 2019

BUY
$18.5 - $25.47 $110,963 - $152,769
5,998 Added 28.89%
26,757 $530,000
Q1 2019

May 06, 2019

BUY
$14.62 - $22.13 $303,496 - $459,396
20,759 New
20,759 $437,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.